en/health – 21. oldal
- GLP-1 Weight-Loss Drugs, Celebrity Speculation, and Intermittent Fasting: What’s Real—and What to Watch 2026-02-08
From Ozempic/Wegovy headlines to intermittent fasting hype, weight-loss news is moving fast. Here’s a practical guide to what these trends mean for safety, access, and long-term health.
- Weight-Loss Drugs, Knockoffs, and Safety: What Recent Headlines Mean for Your Health 2026-02-08
Recent news highlights both the popularity and the pitfalls of modern weight-loss medications. Here’s what to know about risks, “knockoff” products, and practical steps to protect your health.
- Cheaper Ozempic-Style Drugs, Knockoffs Pulled, and New Safety Fears: What’s Happening in Weight-Loss Medicine 2026-02-08
Weight-loss drugs are colliding with affordability pushes, aggressive direct-to-consumer marketing, and renewed worries about side effects. Here’s what the latest headlines mean for patients—and how to make safer choices.
- Hims & Hers Halts Copycat Weight-Loss Pill: What It Means for Patients and the GLP-1 Market 2026-02-08
Hims & Hers pulled back a planned compounded “copycat” weight-loss pill after regulatory scrutiny and legal threats. Here’s what the move signals for patient safety, access, and the fast-changing GLP-1 weight-loss landscape.
- Hims & Hers Pulls Compounded “Copycat” Obesity Pill: What It Means for Patients and Safe Weight-Loss Care 2026-02-08
Hims & Hers has stepped back from a compounded, copycat obesity pill amid regulatory and legal pressure. Here’s what the episode reveals about compounded GLP-1 medications, patient safety, and how to evaluate telehealth weight-loss options.
- Weight-Loss in 2026: GLP-1 Hype, Crackdowns, and What Actually Helps Your Health 2026-02-07
Weight-loss drugs, celebrity stories, and aggressive marketing are everywhere—but so are regulatory warnings and risky knockoffs. Here’s a practical, health-first guide to safer choices, sustainable habits, and what to ask your doctor.
- Weight Loss in the Spotlight: What Celebrity Posts, New Injections and Supplements Get Right—and Wrong 2026-02-07
From viral before-and-after photos to talk of “protein shots” and citrus-based supplements, weight loss headlines can blur the line between health information and hype. Here’s how to interpret the trends with evidence-informed basics and safer next steps.
- Weight Loss in 2026: Medication Risks, Protein Trends, and the Mental Health Side of Transformation 2026-02-07
Weight loss stories are everywhere—from overdoses tied to medications to new protein “shot” trends and celebrity transformations. Here’s a practical, health-first guide to what these headlines mean and how to approach weight loss more safely.
- GLP-1 Weight-Loss Injections: Why Poison-Control Calls Are Rising and What Safe Use Looks Like 2026-02-07
Poison-control calls linked to injectable weight-loss drugs are climbing as demand grows and DIY or compounded products proliferate. Here’s what’s driving the risk—and practical steps to use GLP-1 medications more safely.
- FDA Moves to Curb “Copycat” GLP-1 Weight-Loss Drugs as Safety Calls Rise 2026-02-07
US regulators are stepping up enforcement against unapproved “copycat” GLP-1 weight-loss injections amid reports of dosing mistakes, overdoses, and rising poison-control calls. Here’s what the crackdown means for patients—and how to reduce risk if you use a GLP-1 medication.